Free Trial
CVE:HEM

Hemostemix (HEM) Stock Price, News & Analysis

Hemostemix logo
C$0.14 -0.01 (-6.90%)
As of 07/8/2025 12:16 PM Eastern

About Hemostemix Stock (CVE:HEM)

Key Stats

Today's Range
C$0.14
C$0.15
50-Day Range
C$0.08
C$0.15
52-Week Range
C$0.04
C$0.43
Volume
313,700 shs
Average Volume
409,782 shs
Market Capitalization
C$19.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HEM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hemostemix and its competitors with MarketBeat's FREE daily newsletter.

HEM Stock News Headlines

Hemostemix Closes $469,366 Private Placement
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
See More Headlines

HEM Stock Analysis - Frequently Asked Questions

Hemostemix's stock was trading at C$0.12 on January 1st, 2025. Since then, HEM shares have increased by 12.5% and is now trading at C$0.14.

Shares of HEM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Hemostemix investors own include Iplayco (IPC), Capricor Therapeutics (CAPR), Golden Share Resources (GSH), Nuvilex (PMCB), Algernon Pharmaceuticals (AGNPF), Defense Metals (DFMTF) and NIO (NIO).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:HEM
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$5.00 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.01 per share
Price / Cash Flow
10.77
Book Value
C($0.10) per share
Price / Book
-1.36

Miscellaneous

Free Float
N/A
Market Cap
C$19.67 million
Optionable
Not Optionable
Beta
0.20
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (CVE:HEM) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners